SCHEMBL8310012

SCHEMBL8310012

CC(=NOCCOC1CCCCO1)c1ccc(-c2ccccc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.43
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ADORA3 P0DMS8 1/20 0.35
MGLL Q99685 2/20 0.33
TGFBR1 P36897 2/20 0.33
TGFBR2 P37173 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
HTR2C P28335 1/20 0.33
KCNH2 Q12809 1/20 0.33
MCHR1 Q99705 1/20 0.33
NR1H4 Q96RI1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308833 0.81 PPARG (0.48) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL3083559 0.81 L3MBTL1 (0.47) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL3083561 0.81 L3MBTL1 (0.47) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL8309057 0.80 KDM4C (0.39) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL8308456 0.80 KDM4C (0.44) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL8307747 0.79 MEN1 (0.39) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL8306603 0.75 HIF1A (0.42) L3MBTL1NPC1RAB9A
SCHEMBL8306601 0.75 HIF1A (0.42) L3MBTL1NPC1RAB9A
SCHEMBL8387426 0.74 MEN1 (0.42) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL8304479 0.73 NPC1 (0.43) KDM4CMEN1KMT2AL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed